Biological Therapies in Systemic Lupus Erythematosus: Current Evidence, Emerging Targets, and Future Directions

Authors

  • Yasser Abd Elmonem El -Hendy, Ghada Elsaid Amr, Osama Ragab Youssif, Ahmed Noaman Elsayed,Mohamed Elmarzouky Kewan Author

DOI:

https://doi.org/10.48047/tek2k723

Keywords:

Biological Therapies, Systemic Lupus Erythematosus, Future Directions

Abstract

Background: Systemic lupus erythematosus (SLE) is a complex multisystem autoimmune disease frequently encountered in internal medicine, characterized by dysregulated innate and adaptive immune responses leading to widespread tissue injury. Despite advances in conventional immunosuppressive therapy, many patients experience relapses, treatment resistance, or  drug-related toxicity

Downloads

Download data is not yet available.

References

Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2021;385(6):538–551.

Fanouriakis A, Kostopoulou M, Bertsias G, Boumpas DT. Treatment update in lupus and future prospects. Ann Rheum Dis. 2021;80(1):14–25.

Downloads

Published

2024-11-20

How to Cite

Biological Therapies in Systemic Lupus Erythematosus: Current Evidence, Emerging Targets, and Future Directions (Yasser Abd Elmonem El -Hendy, Ghada Elsaid Amr, Osama Ragab Youssif, Ahmed Noaman Elsayed,Mohamed Elmarzouky Kewan , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 6228-6241. https://doi.org/10.48047/tek2k723